Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults (Q43770759)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Brian H Kushner

1

object named as

Kushner BH

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Nai-Kong V Cheung

2

object named as

Cheung NK

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

3

object named as

Kramer K

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Calleja E

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Boulad F

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

551-556

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

A phase II evaluation of thiotepa in pediatric central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

High-dose chemotherapy regimens for solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

21 January 2018

Myeloablative combination chemotherapy without total body irradiation for neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of topotecan for pediatric patients with malignant solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of topotecan in patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703213

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703213

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43770759&oldid=2206249241"